Skip to content
← Back to this collection

PUBLICATIONS · 22184409

Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2012 Feb 16
First author
Moskowitz CH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Moskowitz CH
      type
      Author
    2. name
      Matasar MJ
      type
      Author
    3. name
      Zelenetz AD
      type
      Author
    4. name
      Nimer SD
      type
      Author
    5. name
      Gerecitano J
      type
      Author
    6. name
      Hamlin P
      type
      Author
    7. name
      Horwitz S
      type
      Author
    8. name
      Moskowitz AJ
      type
      Author
    9. name
      Noy A
      type
      Author
    10. name
      Palomba L
      type
      Author
    11. name
      Perales MA
      type
      Author
    12. name
      Portlock C
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Moskowitz CH
      type
      Author
    2. name
      Matasar MJ
      type
      Author
    3. name
      Zelenetz AD
      type
      Author
    4. name
      Nimer SD
      type
      Author
    5. name
      Gerecitano J
      type
      Author
    6. name
      Hamlin P
      type
      Author
    7. name
      Horwitz S
      type
      Author
    8. name
      Moskowitz AJ
      type
      Author
    9. name
      Noy A
      type
      Author
    10. name
      Palomba L
      type
      Author
    11. name
      Perales MA
      type
      Author
    12. name
      Portlock C
      type
      Author
    bibliography ids
    1. nci-bib-a1f4c5408dd59c32c5496556
    book metadata
    content sha256
    a949c9872742390cec40c06190413f10545f2122afe1714754a23115bfb5f925
    document type
    citation
    dois
    1. 10.1182/blood-2011-10-388058
    electronic publication date
    display
    2011 Dec 19
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:22184409
    immutable id
    pubmed:22184409@a949c9872742390cec40c06190413f10545f2122afe1714754a23115bfb5f925
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    7
    name
    Blood
    nlm unique id
    7603509
    pages
    1665-70
    volume
    119
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      22184409
      provenance
      batch id
      b6284687e167e7da9556
      provider
      NCBI PubMed ESummary
      record sha256
      eb785e3079c8823f9e62e8473fa8854b944a05a311315e46b191666013e1f27c
      response sha256
      64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
      retrieved at
      2026-09-09T23:46:45.216259+00:00
      publication date
      display
      2012 Feb 16
      precision
      day
      year
      2012
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/22184409/
      title
      Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.

      Preserved source evidence · Not medical advice